Pulmonary hypertension secondary to interstitial lung disease

被引：1

作者：

Shlobin, Oksana A. ^{[1
]}

Nathan, Steven D. ^{[1
]}

机构：

[1] Inova Heart & Vasc Inst, Adv Lung Dis & Transplant Program, Falls Church, VA 22042 USA

来源：

EXPERT REVIEW OF RESPIRATORY MEDICINE | 2011年 / 5卷 / 02期

关键词：

catheterization; histiocytosis; hypertension; interstitial; Langerhans cell; lung diseases; lymphangioleiomyomatosis; pulmonary; pulmonary fibrosis; research design; sarcoidosis; scleroderma; Swan-Ganz; systemic; VENTRICULAR DIASTOLIC DYSFUNCTION; ARTERIAL-HYPERTENSION; SYSTEMIC-SCLEROSIS; SYSTOLIC PRESSURE; CONTROLLED-TRIAL; WALK DISTANCE; SARCOIDOSIS; FIBROSIS; HISTIOCYTOSIS; SILDENAFIL;

D O I：

10.1586/ERS.11.11

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Interstitial lung diseases (ILDs) may be complicated by the development of pulmonary hypertension (PH), which is associated with worse functional impairment and a poorer prognosis. This article reviews the current state of knowledge on the prevalence, pathogenesis, diagnosis and prognosis of ILD-related PH. Whether the treatment of ILD-related PH changes clinical outcomes is currently unknown, but the current studies are summarized and the authors' perspective is offered.

引用

页码：179 / 189

页数：11

共 91 条

[1]

[Anonymous], 1963, CIRCULATION, V27, P594, DOI DOI 10.1161/01.CIR.27.4.594

[2] Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease [J].

Arcasoy, SM ;

Christie, JD ;

Ferrari, VA ;

Sutton, MS ;

Zisman, DA ;

Blumenthal, NP ;

Pochettino, A ;

Kotloff, RM .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (05) :735-740

[3]

Badesch DB, 2009, AM J RESP CRIT CARE, V179

[4] Medical therapy for pulmonary arterial hypertension - Updated ACCP evidence-based clinical practice guidelines [J].

Badesch, David B. ;

Abman, Steven H. ;

Simonneau, Gerald ;

Rubin, Lewis J. ;

McLaughlin, Vallerie V. .

CHEST, 2007, 131 (06) :1917-1928

[5] Treatment of Sarcoidosis-Associated Pulmonary Hypertension A Two-Center Experience [J].

Barnett, Christopher F. ;

Bonura, Eric J. ;

Nathan, Steven D. ;

Ahmad, Shahzad ;

Shlobin, Oksana A. ;

Osei, Kwabena ;

Zaiman, Ari L. ;

Hassoun, Paul M. ;

Moller, David R. ;

Barnett, Scott D. ;

Girgis, Reda E. .

CHEST, 2009, 135 (06) :1455-1461

[6] Diagnosis and differential assessment of pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

Torbicki, A ;

Sitbon, O ;

Krowka, MJ ;

Olschewski, H ;

Gaine, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :40S-47S

[7] Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension [J].

Barst, Robyn J. ;

Gibbs, J. Simon R. ;

Ghofrani, Hossein A. ;

Hoeper, Marius M. ;

McLaughlin, Vallerie V. ;

Rubin, Lewis J. ;

Sitbon, Olivier ;

Tapson, Victor F. ;

Galie, Nazzareno .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (01) :S78-S84

[8]

Baughman RP, 2006, SARCOIDOSIS VASC DIF, V23, P108

[9] Survival in Sarcoidosis-Associated Pulmonary Hypertension The Importance of Hemodynamic Evaluation [J].

Baughman, Robert P. ;

Engel, Peter J. ;

Taylor, Lisa ;

Lower, Elyse E. .

CHEST, 2010, 138 (05) :1078-1085

[10] Steroid-responsive pulmonary hypertension in a patient with Langerhans' cell granulomatosis (histiocytosis X) [J].

Benyounes, B ;

Crestani, B ;

Couvelard, A ;

Vissuzaine, C ;

Aubier, M .

CHEST, 1996, 110 (01) :284-286

← 1 2 3 4 5 6 7 8 9 10 →